Abingdon Health Plc Stock Revenue
| ABDX Stock | 7.00 0.25 3.45% |
Abingdon Health Plc fundamentals help investors to digest information that contributes to Abingdon Health's financial success or failures. It also enables traders to predict the movement of Abingdon Stock. The fundamental analysis module provides a way to measure Abingdon Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Abingdon Health stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 6.1 M | 1.4 M |
Abingdon | Revenue |
Abingdon Health Plc Company Revenue Analysis
Abingdon Health's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Abingdon Health Revenue | 6.13 M |
Most of Abingdon Health's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Abingdon Health Plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of Abingdon
Projected quarterly revenue analysis of Abingdon Health Plc provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Abingdon Health match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Abingdon Health's stock price.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Abingdon Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, Abingdon Health Plc reported 6.13 M of revenue. This is 99.92% lower than that of the Biotechnology sector and 99.69% lower than that of the Health Care industry. The revenue for all United Kingdom stocks is 99.93% higher than that of the company.
Abingdon Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Abingdon Health's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Abingdon Health could also be used in its relative valuation, which is a method of valuing Abingdon Health by comparing valuation metrics of similar companies.Abingdon Health is currently under evaluation in revenue category among its peers.
Abingdon Fundamentals
| Return On Equity | -0.49 | ||||
| Return On Asset | -0.18 | ||||
| Profit Margin | (0.21) % | ||||
| Operating Margin | (0.04) % | ||||
| Current Valuation | 13.35 M | ||||
| Shares Outstanding | 189.52 M | ||||
| Shares Owned By Insiders | 43.15 % | ||||
| Shares Owned By Institutions | 33.31 % | ||||
| Price To Book | 6.11 X | ||||
| Price To Sales | 2.24 X | ||||
| Revenue | 6.13 M | ||||
| Gross Profit | 2.08 M | ||||
| EBITDA | (916 K) | ||||
| Net Income | (1.27 M) | ||||
| Total Debt | 1.05 M | ||||
| Book Value Per Share | 0.01 X | ||||
| Cash Flow From Operations | (1.66 M) | ||||
| Target Price | 78.0 | ||||
| Number Of Employees | 84 | ||||
| Beta | 0.21 | ||||
| Market Capitalization | 13.74 M | ||||
| Total Asset | 5.09 M | ||||
| Retained Earnings | (28.76 M) | ||||
| Working Capital | 2.64 M | ||||
| Net Asset | 5.09 M |
About Abingdon Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Abingdon Health Plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Abingdon Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Abingdon Health Plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Abingdon Stock Analysis
When running Abingdon Health's price analysis, check to measure Abingdon Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abingdon Health is operating at the current time. Most of Abingdon Health's value examination focuses on studying past and present price action to predict the probability of Abingdon Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abingdon Health's price. Additionally, you may evaluate how the addition of Abingdon Health to your portfolios can decrease your overall portfolio volatility.